<DOC>
	<DOCNO>NCT02233842</DOCNO>
	<brief_summary>Background : - People cancer medical problem smoke . Some study show smoke even make cancer treatment less effective . Researchers want teach people tobacco use affect people cancer diagnosis . They want come question people cancer survive cancer . The question use cigarette tobacco product second-hand smoke . The question use understand use tobacco affect people cancer , , treatment . This help doctor plan treat people cancer create program help people quit smoking future . Objective : - To evaluate refine question assess tobacco use . Eligibility : - Adults age 21 old cancer cancer survivor . The cancer site stage . Design : - This study take 1 hour . - Participants meet one-on-one interviewer . They fill questionnaire talk question . Participants explain easy hard answer question decide answer . - All participant ask similar question . Specific question base participant experience tobacco product . - There follow-up activity .</brief_summary>
	<brief_title>Cognitive Testing Tobacco Use Measurement Items Administration With Cancer Patients Survivors</brief_title>
	<detailed_description>Background : Studies compare cancer patient smoke cigarette time diagnosis former never smoker demonstrate increase difficulty surgical wound heal treatment morbidity ; reduce radiation chemotherapy efficacy ; reduce time recurrence , progression , second primary cancer ; increase mortality . Some study find smoke interacts cancer therapy efficacy . Cigarette smoke prevalent among patient lung head neck cancer , rate high 40 % 60 % time diagnosis . The rate smoking among cancer survivor estimate 21 % lung cancer survivor 39 % survivor cancer . ( 11 ) Only 22 % NCI-funded phase III trial conduct Cooperative Groups record patient cigarette smoke status among patient time enrollment , 4 % record cigarette smoke status follow-up . We need examine impact tobacco use wider range therapeutic regimen setting , detailed longitudinal tobacco use assessment . Research area impede inadequate assessment tobacco use cancer diagnosis lack valid , harmonized measure tailor trajectory cancer diagnosis , treatment survivorship . ( 15 ) The NCI-AACR Cancer Patient Tobacco Use Assessment Task Force form 2013 develop recommendation assess tobacco use cancer patient . The long- range goal Task Force advance state knowledge effect tobacco use cancer diagnosis , inform cancer treatment decision-making guide patient provider regard time clinical significance tobacco cessation . Objectives : To evaluate refine propose questionnaire item assess tobacco use . Eligibility : Cancer patient disease site , stage , extent prior therapy age great equal 21 year . Design : This study evaluate refine propose questionnaire item assess tobacco use cancer patient survivor population . This study purely qualitative . No research hypotheses test study . There therapy , administration agent ( ) , image administer part study . Participants ask answer question discuss answer question . Patients consent participate session last one hour . They complete questionnaire tobacco use answer debrief question interviewer assess question comprehension , ease answering , accuracy response .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Thymus Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients prior confirm cancer diagnosis treat follow Center Cancer Research , Bethesda , Maryland , eligible . 3.1.1 Cancer patient disease site , stage , extent prior therapy eligible . 3.1.2 Patients age 21 year old eligible . The item intend use adult population , need test representative population . 3.1.3 Additional eligibility criterion : Individuals must able understand willing answer item tobacco use . Individuals must able read speak English . For purpose study , limit participation adult selfconsent selfreport English ( vs. able respond aid translator ) . The material develop English ; intend cognitive test English language questionnaire . ( If Spanish translation item develop future , separate cognitive test effort need ensure cultural equivalence item . ) 3.1.4 Participants must able understand willing sign write informed consent document . All participant ask provide explicit consent . 3.1.5 Participants eligible whether never use tobacco product type , use type tobacco previously , current tobacco user type . ( Participant recruitment design enroll variety patient respect tobacco use . ) EXCLUSION CRITERIA : None . ( Patients may already begin protocol treatment . ) INCLUSION OF WOMEN AND MINORITIES : Both men woman race ethnic group eligible participation test item . In fact , extent possible , try include diversity demographic characteristic ( age , race , gender , education level ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>110 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Qualitative Data</keyword>
	<keyword>Questionnaire</keyword>
</DOC>